AAAAAA

   
Results: 1-9 |
Results: 9
PHARMACOKINETICS OF THE 5HT(3) RECEPTOR ANTAGONIST TROPISETRON IN CHILDREN
Authors: GAEDICKE G ERTTMANN R HENZE G HARTMANN W DRECHSLER S GRASS P FAERBER L KUTZ K
Citation: G. Gaedicke et al., PHARMACOKINETICS OF THE 5HT(3) RECEPTOR ANTAGONIST TROPISETRON IN CHILDREN, Pediatric hematology and oncology, 13(5), 1996, pp. 405-416
SANDOSTATIN(R) LAR(R) (MICROENCAPSULATED OCTREOTIDE ACETATE) IN ACROMEGALY - PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIPS
Authors: GRASS P MARBACH P BRUNS C LANCRANJAN I
Citation: P. Grass et al., SANDOSTATIN(R) LAR(R) (MICROENCAPSULATED OCTREOTIDE ACETATE) IN ACROMEGALY - PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIPS, Metabolism, clinical and experimental, 45(8), 1996, pp. 27-30
SANDOSTATIN(R) LAR(R) - A PROMISING THERAPEUTIC TOOL IN THE MANAGEMENT OF ACROMEGALIC PATIENTS
Authors: LANCRANJAN I BRUNS C GRASS P JAQUET P JERVELL J KENDALLTAYLOR P LAMBERTS SWJ MARBACH P ORSKOV H PAGANI G SHEPPARD M SIMIONESCU L
Citation: I. Lancranjan et al., SANDOSTATIN(R) LAR(R) - A PROMISING THERAPEUTIC TOOL IN THE MANAGEMENT OF ACROMEGALIC PATIENTS, Metabolism, clinical and experimental, 45(8), 1996, pp. 67-71
SPONTANEOUS CONSCIOUS COVERT COGNITION STATES AND BRAIN ELECTRIC SPECTRAL STATES IN CANONICAL CORRELATIONS
Authors: LEHMANN D GRASS P MEIER B
Citation: D. Lehmann et al., SPONTANEOUS CONSCIOUS COVERT COGNITION STATES AND BRAIN ELECTRIC SPECTRAL STATES IN CANONICAL CORRELATIONS, International journal of psychophysiology, 19(1), 1995, pp. 41-52
SANDOSTATIN LAR(R) - PHARMACOKINETICS, PHARMACODYNAMICS, EFFICACY, AND TOLERABILITY IN ACROMEGALIC PATIENTS
Authors: LANCRANJAN I BRUNS C GRASS P JAQUET P JERVELL J KENDALLTAYLOR P LAMBERTS SWJ MARBACH P ORSKOV H PAGANI G SHEPPARD M SIMIONESCU L
Citation: I. Lancranjan et al., SANDOSTATIN LAR(R) - PHARMACOKINETICS, PHARMACODYNAMICS, EFFICACY, AND TOLERABILITY IN ACROMEGALIC PATIENTS, Metabolism, clinical and experimental, 44(1), 1995, pp. 18-26
PHARMACOKINETICS OF THE ACE-INHIBITOR SPI RAPRIL IN PATIENTS WITH CHRONIC-RENAL-FAILURE
Authors: HAUFE CC SERAKOWSKI B GRASS P JANSA U WEIDINGER G STEIN G
Citation: Cc. Haufe et al., PHARMACOKINETICS OF THE ACE-INHIBITOR SPI RAPRIL IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Nieren- und Hochdruckkrankheiten, 23(5), 1994, pp. 213-216
A COMPARISON OF OCTREOTIDE, BROMOCRIPTINE, OR A COMBINATION OF BOTH DRUGS IN ACROMEGALY
Authors: FLOGSTAD AK HALSE J GRASS P ABISCH E DJOSELAND O KUTZ K BODD E JERVELL J
Citation: Ak. Flogstad et al., A COMPARISON OF OCTREOTIDE, BROMOCRIPTINE, OR A COMBINATION OF BOTH DRUGS IN ACROMEGALY, The Journal of clinical endocrinology and metabolism, 79(2), 1994, pp. 461-465
PHARMACOKINETICS AND HEMODYNAMIC-EFFECTS OF A SINGLE ORAL DOSE OF THENOVEL ACE-INHIBITOR SPIRAPRIL IN PATIENTS WITH CHRONIC LIVER-DISEASE
Authors: KRAHENBUHL S GRASS P SURVE A KUTZ K REICHEN J
Citation: S. Krahenbuhl et al., PHARMACOKINETICS AND HEMODYNAMIC-EFFECTS OF A SINGLE ORAL DOSE OF THENOVEL ACE-INHIBITOR SPIRAPRIL IN PATIENTS WITH CHRONIC LIVER-DISEASE, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 247-253
EFFECTS OF DICLOFENAC ON ISRADIPINE PHARMACOKINETICS AND PLATELET-AGGREGATION IN VOLUNTEERS
Authors: SOMMERS DK KOVARIK JM MEYER EC VANWYK M SNYMAN JR BLOM M OTT S GRASS P KUTZ K
Citation: Dk. Sommers et al., EFFECTS OF DICLOFENAC ON ISRADIPINE PHARMACOKINETICS AND PLATELET-AGGREGATION IN VOLUNTEERS, European Journal of Clinical Pharmacology, 44(4), 1993, pp. 391-393
Risultati: 1-9 |